Neurovisceral porphyrias: what a hematologist needs to know.

  title={Neurovisceral porphyrias: what a hematologist needs to know.},
  author={Herbert L. Bonkovsky},
  journal={Hematology. American Society of Hematology. Education Program},
  • H. Bonkovsky
  • Published 2005
  • Medicine
  • Hematology. American Society of Hematology. Education Program
The acute or inducible hepatic porphyrias comprise four inherited disorders of heme biosynthesis. They usually remain asymptomatic for most of the lifespan of individuals who inherit the specific enzyme deficiencies but may cause life-threatening attacks of neurovisceral symptoms. Failure to consider the diagnosis frequently delays effective treatment, and inappropriate diagnostic tests and/or mistaken interpretation of results may lead to misdiagnosis and inappropriate treatment. The four… 

Figures and Tables from this paper

Liver transplantation in the management of porphyria

An overview of porphyria with diagnostic approaches and management strategies for specific porphyrias and recommendations for LT with indications, pretransplant evaluation, and posttransplant management is provided.

A case of fatal acute intermittent porphyria: laboratory diagnosis and pathogenesis considerations / Un caz fatal de porfirie acută intermitentă: diagnostic de laborator şi consideraţii patogenice

A fatal case of a 39-years old female who presented acute abdominal pain followed by severe peripheral nervous system lesions with tetraplegia is presented and the diagnosis of AIP was established and the patient died after 3 weeks from onset due to a septic shock.

Acute intermittent porphyria--diagnostic and treatment traps.

The case of a 38-years-old patient admitted for persistent abdominal pain that previously presented two generalized convulsive seizures died seven weeks after the initial presentation of the disease, with tetraplegia and severe respiratory failure.

[Hereditary coproporphyria from clinician's point of view--a case report].

Porphyrias should always be taken into consideration in doubtful, frequently dramatic clinical pictures characterized by neurovisceral symptoms and precipitating factors of acute porphyria attacks must never be neglected.

Porphyric neuropathy.

Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria

The mainstay treatment in the cutaneous porphyrias is avoidance of sunlight exposure, and in erythropoietic protoporphyria, light-protective beta-carotene is prescribed.

Porfiria aguda intermitente la importancia de ampliar la perspectiva del diagnóstico diferencial

The determination of total porphyrins in blood and urine and porphobilinogen and delta-aminolevulinic acid in urine made in Buenos Aires confirmed the definitive diagnosis of acute intermittent porphyria, a disease with high mortality and rarely observed in this country.

Treatment Options in Acute Porphyria, Treatment Options in Acute Porphyria, Porphyria Cutanea Tarda, Porphyria Cutanea Tarda, and Erythropoietic Protoporphyria and Erythropoietic Protoporphyria

Most porphyrias have low clinical penetrance, and symptoms are often triggered by specific endogenous or environmental porphyrogenic factors, but the recessive condi-tions exhibit very low residual enzyme activity and high clinical penetraterance, often with manifestations from early childhood.



Acute intermittent porphyria: studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias.

It is suggested that porphyrin precursor toxicity is primarily responsible for the acute neurologic attacks in heterozygous AIP and other porphyrias and suggest that the neurologic manifestations of a severely affected infant with HD-AIP result from porphyrsine precursor toxicity rather than heme deficiency.

Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology.

Enzymatic assays and DNA-based testing are not usually needed for rapid diagnosis or management of symptomatic subjects, but they are useful for kindred evaluation and genetic counseling.

Liver Transplantation in a Boy with Acute Porphyria Due to Aminolaevulinate Dehydratase Deficiency

  • S. ThunellA. Henrichson J. Lundgren
  • Medicine
    European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies
  • 1992
The clinical and biochemical outcome of a liver transplantation in a seven-year-old boy with acute porphyria due to aminolaevulinate dehydratase deficiency is described and the patient has been able to withstand several porphyrinogenic challenges without increasing the excretion.

Harderoporphyria: a variant hereditary coproporphyria.

Three siblings with intense jaundice and hemolytic anemia at birth were found to excrete a high level of coproporphyrin in their urine and feces; the pattern of fecal porphyrin excretion was atypical

Recovery from a variegate porphyria by a liver transplantation

  • N. StojebaC. Meyer J. Deybach
  • Medicine, Biology
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2004
A step‐by‐step perioperative management protocol for acute hepatic porphyrias is described and a case of liver transplantation is described with a recovery from a variegate porphyria.

The effect of oral activated charcoal on the course of congenital erythropoietic porphyria

It is concluded that charcoal therapy in porphyria may not be without risk, and should be used with caution, and the use of charcoal was associated with an apparent exacerbation of the biochemical activity of the disease following an initial period of remission.

Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.

Infusions of heme administered intravenously, complexed to human serum albumin are safe and effective in repleting deficient heme pools and hemoproteins in patients with acute porphyria and that activities of cytochrome(s) P-450 in normal subjects may also be increased by heme administration.